HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of oral sodium bicarbonate in patients with CKD.

AbstractBACKGROUND AND OBJECTIVES:
Metabolic acidosis contributes to muscle breakdown in patients with CKD, but whether its treatment improves functional outcomes is unknown. The choice of dose and tolerability of high doses remain unclear. In CKD patients with mild acidosis, this study evaluated the dose-response relationship of alkali with serum bicarbonate, its side effect profile, and its effect on muscle strength.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS:
In this single-blinded pilot study from March of 2009 to August of 2010, 20 adults with estimated GFR 15-45 ml/min per 1.73 m(2) and serum bicarbonate 20-24 mEq/L were treated during successive 2-week periods with placebo followed by escalating oral NaHCO3 doses (0.3, 0.6, and 1.0 mEq/kg per day). At each visit, handgrip strength and time required to complete 5 and 10 repetitions of a sit-to-stand test were measured.
RESULTS:
Each 0.1 mEq/kg per day increase in dose produced a 0.33 mEq/L (95% confidence interval=0.23-0.43 mEq/L) higher serum bicarbonate. Sit-to-stand time improved after 6 weeks of oral NaHCO3 (23.8±1.4 versus 22.2±1.6 seconds for 10 repetitions, P=0.002), and urinary nitrogen excretion decreased (-0.70 g/g creatinine [95% confidence interval=-1.11 to -0.30] per 0.1 mEq/kg per day higher dose). No statistically significant change was seen in handgrip strength (29.5±9.6 versus 28.4±9.4 kg, P=0.12). Higher NaHCO3 doses were not associated with increased BP or greater edema.
CONCLUSIONS:
NaHCO3 supplementation produces a dose-dependent increase in serum bicarbonate and improves lower extremity muscle strength after a short-term intervention in CKD patients with mild acidosis. Long-term studies are needed to determine if this finding translates into improved functional status.
AuthorsMatthew K Abramowitz, Michal L Melamed, Carolyn Bauer, Amanda C Raff, Thomas H Hostetter
JournalClinical journal of the American Society of Nephrology : CJASN (Clin J Am Soc Nephrol) Vol. 8 Issue 5 Pg. 714-20 (May 2013) ISSN: 1555-905X [Electronic] United States
PMID23393105 (Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Sodium Bicarbonate
Topics
  • Acidosis (blood, diagnosis, drug therapy, physiopathology)
  • Administration, Oral
  • Aged
  • Dose-Response Relationship, Drug
  • Female
  • Hand Strength
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Muscle, Skeletal (drug effects, physiopathology)
  • New York
  • Pilot Projects
  • Recovery of Function
  • Renal Insufficiency, Chronic (blood, diagnosis, drug therapy, physiopathology)
  • Single-Blind Method
  • Sodium Bicarbonate (administration & dosage, adverse effects, blood)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: